{"title":"肺功能受损与脊椎关节炎风险之间的关系：英国生物银行的一项横断面研究。","authors":"Ying Zhu, Zijian Kang, Chen Zhu, Dajiang Du, Jianzheng Zhang, Qiang Tong","doi":"10.1177/1759720X251371112","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Impaired lung function has been noted in individuals with spondyloarthritis (SpA). However, a comprehensive summary of the existing evidence related to these conditions is still lacking.</p><p><strong>Objective: </strong>The aim of the study is to explore the association between impaired lung function and the prevalence and incidence of SpA, utilizing data from the UK Biobank.</p><p><strong>Methods: </strong>A total of 411,780 participants with complete spirometry data were included in the study. Logistic regression and Cox regression models were employed to investigate the association between impaired lung function and the prevalence/incidence of SpA. In addition, restricted cubic spline (RCS) analysis was applied to evaluate the nonlinear relationships between forced expiratory volume in 1 s (FEV1) and/or forced vital capacity of the predicted value and SpA incidence.</p><p><strong>Design: </strong>A cross-sectional study was conducted by using UK Biobank data from 411,780 participants with complete lung function records and HLA-B27 genotype. In addition, a prospective cohort of 409,069 individuals without baseline SpA and lost follow-up was followed longitudinally to assess incident SpA risk.</p><p><strong>Result: </strong>The prevalence of SpA was significantly higher in individuals with preserved ratio impaired spirometry (PRISm) compared to those with normal spirometry, as evidenced by adjusted odds ratio (OR; 95% confidence interval (CI)) of 1.538 (1.409-1.680) for SpA. Over a median follow-up period of 14.64 years, 1637 participants (0.40%, 1637/409,069) developed SpA, with PRISm associated with an elevated risk for incident SpA (adjusted hazard ratio (95% CI): 1.249 (1.098-1.420)) when compared to normal spirometry. Furthermore, RCS analysis revealed a nonlinear relationship between FEV1 %pred and the risk of developing SpA (overall <i>p</i> < 0.001 and nonlinear <i>p</i> = 0.011).</p><p><strong>Conclusion: </strong>The study unveiled a significant association between impaired lung function and the prevalence of SpA. Individuals with PRISm may have an elevated risk of incident SpA.</p>","PeriodicalId":23056,"journal":{"name":"Therapeutic Advances in Musculoskeletal Disease","volume":"17 ","pages":"1759720X251371112"},"PeriodicalIF":4.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402665/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association between impaired lung function and risk of spondyloarthritis: a cross-sectional study in the UK Biobank.\",\"authors\":\"Ying Zhu, Zijian Kang, Chen Zhu, Dajiang Du, Jianzheng Zhang, Qiang Tong\",\"doi\":\"10.1177/1759720X251371112\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Impaired lung function has been noted in individuals with spondyloarthritis (SpA). However, a comprehensive summary of the existing evidence related to these conditions is still lacking.</p><p><strong>Objective: </strong>The aim of the study is to explore the association between impaired lung function and the prevalence and incidence of SpA, utilizing data from the UK Biobank.</p><p><strong>Methods: </strong>A total of 411,780 participants with complete spirometry data were included in the study. Logistic regression and Cox regression models were employed to investigate the association between impaired lung function and the prevalence/incidence of SpA. In addition, restricted cubic spline (RCS) analysis was applied to evaluate the nonlinear relationships between forced expiratory volume in 1 s (FEV1) and/or forced vital capacity of the predicted value and SpA incidence.</p><p><strong>Design: </strong>A cross-sectional study was conducted by using UK Biobank data from 411,780 participants with complete lung function records and HLA-B27 genotype. In addition, a prospective cohort of 409,069 individuals without baseline SpA and lost follow-up was followed longitudinally to assess incident SpA risk.</p><p><strong>Result: </strong>The prevalence of SpA was significantly higher in individuals with preserved ratio impaired spirometry (PRISm) compared to those with normal spirometry, as evidenced by adjusted odds ratio (OR; 95% confidence interval (CI)) of 1.538 (1.409-1.680) for SpA. Over a median follow-up period of 14.64 years, 1637 participants (0.40%, 1637/409,069) developed SpA, with PRISm associated with an elevated risk for incident SpA (adjusted hazard ratio (95% CI): 1.249 (1.098-1.420)) when compared to normal spirometry. Furthermore, RCS analysis revealed a nonlinear relationship between FEV1 %pred and the risk of developing SpA (overall <i>p</i> < 0.001 and nonlinear <i>p</i> = 0.011).</p><p><strong>Conclusion: </strong>The study unveiled a significant association between impaired lung function and the prevalence of SpA. Individuals with PRISm may have an elevated risk of incident SpA.</p>\",\"PeriodicalId\":23056,\"journal\":{\"name\":\"Therapeutic Advances in Musculoskeletal Disease\",\"volume\":\"17 \",\"pages\":\"1759720X251371112\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402665/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Musculoskeletal Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/1759720X251371112\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Musculoskeletal Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1759720X251371112","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
Association between impaired lung function and risk of spondyloarthritis: a cross-sectional study in the UK Biobank.
Background: Impaired lung function has been noted in individuals with spondyloarthritis (SpA). However, a comprehensive summary of the existing evidence related to these conditions is still lacking.
Objective: The aim of the study is to explore the association between impaired lung function and the prevalence and incidence of SpA, utilizing data from the UK Biobank.
Methods: A total of 411,780 participants with complete spirometry data were included in the study. Logistic regression and Cox regression models were employed to investigate the association between impaired lung function and the prevalence/incidence of SpA. In addition, restricted cubic spline (RCS) analysis was applied to evaluate the nonlinear relationships between forced expiratory volume in 1 s (FEV1) and/or forced vital capacity of the predicted value and SpA incidence.
Design: A cross-sectional study was conducted by using UK Biobank data from 411,780 participants with complete lung function records and HLA-B27 genotype. In addition, a prospective cohort of 409,069 individuals without baseline SpA and lost follow-up was followed longitudinally to assess incident SpA risk.
Result: The prevalence of SpA was significantly higher in individuals with preserved ratio impaired spirometry (PRISm) compared to those with normal spirometry, as evidenced by adjusted odds ratio (OR; 95% confidence interval (CI)) of 1.538 (1.409-1.680) for SpA. Over a median follow-up period of 14.64 years, 1637 participants (0.40%, 1637/409,069) developed SpA, with PRISm associated with an elevated risk for incident SpA (adjusted hazard ratio (95% CI): 1.249 (1.098-1.420)) when compared to normal spirometry. Furthermore, RCS analysis revealed a nonlinear relationship between FEV1 %pred and the risk of developing SpA (overall p < 0.001 and nonlinear p = 0.011).
Conclusion: The study unveiled a significant association between impaired lung function and the prevalence of SpA. Individuals with PRISm may have an elevated risk of incident SpA.
期刊介绍：
Therapeutic Advances in Musculoskeletal Disease delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of musculoskeletal disease.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
